Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

DiaSorin SpA (DIAS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
94.90 +1.24    +1.32%
26/04 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 122,640
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 93.72 - 96.00
Type:  Equity
Market:  Italy
ISIN:  IT0003492391 
Diasorin 94.90 +1.24 +1.32%

Diasorin Company Profile

 
Read the DiaSorin SpA company profile to learn more about the business and the management team. View DiaSorin SpA facts about employee data, company products and services, and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

3278

Equity Type

ORD

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Contact Information

Address Via Crescentino
Saluggia, 13040
Italy
Phone 39 01 614871
Fax 39 01 61 48 7628

Top Executives

Name Age Since Title
Chen Menachem Even 60 2007 Chief Commercial Officer, Senior Corporate VP of Commercial Operations & Executive Director
Roberta Somati 54 2013 Independent Non-Executive Director
Fiorella Altruda 71 2016 Independent Director
Francesca Pasinelli 63 2016 Independent Director
Monica Tardivo 53 2016 Independent Director
Ottavia Alfano 52 2013 Statutory Auditor
Stefano Altara 56 2014 Non-Executive Director
Carlo Rosa 57 2006 CEO, GM & Executive Director
Francesco Moscetti 72 2007 Independent Non-Executive Director
Tullia Todros 75 2016 Independent Director
Michele Denegri 54 2007 Non-Executive Chairman
Monica Mannino 54 2016 Chairman of Board of Statutory Auditors
Matteo Michele Sutera 42 2019 Statutory Auditor
Diego Pistone 73 2022 Non-Executive Director
Giovanna Pacchiana Parravicini 54 2022 Independent Non-Executive Director
Luca Melindo 53 2019 Non-Executive Director
Andre-Michel Ballester 65 2022 Lead Independent Non-Executive Director
Giancarlo Boschetti 84 2016 Non-Executive Non-Independent Deputy Chairman
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DIAS Price Commentary

Write your thoughts about DiaSorin SpA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email